• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    PDL BioPharma, Inc. (PDLI)

    -NasdaqGS
    2.92 Up 0.07(2.46%) Feb 5, 4:00PM EST
    |After Hours : 2.92 0.00 (0.00%) Feb 5, 4:49PM EST
    Prev Close:2.85
    Open:2.85
    Bid:2.92 x 1500
    Ask:3.05 x 1000
    1y Target Est:5.25
    Beta:0.660985
    Next Earnings Date:22-Feb-16PDLI Earnings announcement
    Day's Range:2.83 - 2.96
    52wk Range:2.58 - 7.43
    Volume:2,695,705
    Avg Vol (3m):2,398,210
    Market Cap:477.64M
    P/E (ttm):1.75
    EPS (ttm):1.67
    Div & Yield:0.20 (7.02%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    PDLIUp 2.46%477.64M
    AMGNDown 3.25%109.36B
    XOMADown 6.63%104.49M
    SGENDown 3.13%4.44B

    Key Statistics

    Forward P/E (1 yr):4.17
    P/S (ttm):0.94
    Ex-Dividend Date:02-Mar-16

    Analysts

    Annual EPS Est (Dec-15) :1.94
    Quarterly EPS Est (Dec-15) :0.54
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):0.11

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    PDL BioPharma, Inc. manages a portfolio of patents and royalty assets in the United States and Europe. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback